The Use of PET Imaging for Prognostic Integrin α(2)β(1) Phenotyping to Detect Non-Small Cell Lung Cancer and Monitor Drug Resistance Responses

PURPOSE: Growing evidence has demonstrated that aberrant expression of integrin α2β1 might contribute to the invasion, metastasis and drug resistance of non-small cell lung cancer (NSCLC). Thus, the integrin α2β1 targeting (68)Ga-DOTA-A2B1 tracer was validated in NSCLC in contrast to accumulation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chiun-Wei, Hsieh, Wen-Chuan, Hsu, Shih-Ting, Lin, Yi-Wen, Chung, Yi-Hsiu, Chang, Wen-Chi, Chiu, Han, Lin, Yun Han, Wu, Chung-Pu, Yen, Tzu-Chen, Huang, Feng-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667422/
https://www.ncbi.nlm.nih.gov/pubmed/29109795
http://dx.doi.org/10.7150/thno.19304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667422/
https://www.ncbi.nlm.nih.gov/pubmed/29109795
http://dx.doi.org/10.7150/thno.19304

Ejemplares similares